SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-077076
Filing Date
2023-06-30
Accepted
2023-06-30 16:05:31
Documents
14
Period of Report
2023-06-29
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320339d1_8k.htm   iXBRL 8-K 42433
2 EXHIBIT 99.1 tm2320339d1_ex99-1.htm EX-99.1 15247
3 GRAPHIC tm2320339d1_ex99-1ima001.jpg GRAPHIC 2747
  Complete submission text file 0001104659-23-077076.txt   246114

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA irwd-20230629.xsd EX-101.SCH 2977
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20230629_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20230629_pre.xml EX-101.PRE 22371
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2320339d1_8k_htm.xml XML 3616
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 231061688
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences